UB Paderborn / Katalog / Suche / in CDI

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Genome medicine, 2024-02, Vol.16 (1), p.28-18, Article 28

2024

Volltextzugriff (PDF)

Regulation of CRABP-II expression by MycN in Wilms tumor

Experimental cell research, 2008-12, Vol.314 (20), p.3663-3668

2008

Volltextzugriff (PDF)

Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.8100-8108

2006

Volltextzugriff (PDF)

FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones

Head & neck pathology (Totowa, N.J.), 2021-03, Vol.15 (1), p.374-380

2021

Volltextzugriff (PDF)

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

International journal of cancer, 2020-12, Vol.147 (11), p.3152-3159

2020

Volltextzugriff (PDF)

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific reports, 2018-09, Vol.8 (1), p.14445-9, Article 14445

2018

Volltextzugriff (PDF)

A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma

International journal of cancer, 2023-09, Vol.153 (5), p.1026-1034

2023

Volltextzugriff (PDF)

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

Cancer research (Chicago, Ill.), 2021-12, Vol.81 (23), p.5818-5832

2021

Volltextzugriff (PDF)

PET Hydroxyephedrine Imaging of Neuroblastoma

The Journal of nuclear medicine (1978), 1996-01, Vol.37 (1), p.16-21

1996

Volltextzugriff (PDF)

Abstract CT073: Peds-plan, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT073-CT073

2018

Volltextzugriff (PDF)

Hepatosplenic γδ T‐cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults

Pediatric transplantation, 2018-08, Vol.22 (5), p.e13213-n/a

2018

Volltextzugriff (PDF)

Abstract CT089: Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT089-CT089

2023

Volltextzugriff (PDF)

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence

Pediatric blood & cancer, 2016-06, Vol.63 (6), p.1019-1023

2016

Volltextzugriff (PDF)

Multiple Segmental Chromosomal Aberrations in Low-Risk Neuroblastoma are Associated with Metastatic Relapse

Cancer genetics, 2014-06, Vol.207 (6), p.288-288

2014

Volltextzugriff (PDF)

Successful Umbilical Cord Blood Transplantation after Treatment of Rhizopus Infection in an Infant with Hemophagocytic Lymphohistiocytosis

International journal of infectious diseases, 2008-06, Vol.12, p.S5-S5

2008

Volltextzugriff (PDF)

Cutaneous and Mandibular Dual Fungal Infection with Fusarium and Rhizopus Species, in a Child with AML

International journal of infectious diseases, 2008, Vol.12, p.S33-S33

2008

Volltextzugriff (PDF)

nm23-H1 mutation in neuroblastoma

Nature (London), 1994-08, Vol.370 (6488), p.335-336

1994

Volltextzugriff (PDF)

Bioavailability and Pharmacokinetic Features of Etoposide in Childhood Acute Lymphoblastic Leukemia Patients

Leukemia & lymphoma, 2001, Vol.42 (3), p.317-327

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

Regulation of CRABP-II expression by MycN in Wilms tumor

Cellular retinoic acid-binding protein II is a direct transcriptional target of MycN in neuroblastoma

FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

PET Hydroxyephedrine Imaging of Neuroblastoma

Abstract CT073: Peds-plan, pediatric precision laboratory advanced neuroblastoma therapy: Molecular guided therapy for high risk neuroblastoma at diagnosis

Hepatosplenic γδ T‐cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults

Abstract CT089: Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence

Multiple Segmental Chromosomal Aberrations in Low-Risk Neuroblastoma are Associated with Metastatic Relapse

Successful Umbilical Cord Blood Transplantation after Treatment of Rhizopus Infection in an Infant with Hemophagocytic Lymphohistiocytosis

Cutaneous and Mandibular Dual Fungal Infection with Fusarium and Rhizopus Species, in a Child with AML

nm23-H1 mutation in neuroblastoma

Bioavailability and Pharmacokinetic Features of Etoposide in Childhood Acute Lymphoblastic Leukemia Patients

Suchergebnisse filtern